– Gan & Lee Pharmaceuticals presentará nuevos datos sobre tres productos innovadores en la 84ª sesión científica de la Asociación Estadounidense de Diabetes Un ensayo de fase 1b/2a evaluó GZR18 una vez y dos veces por semana, un nuevo análogo de GLP-1, en sujetos chinos con…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.